Protein Structure Analysis: An Experimental Path from Defining the Question to Functional Validation

1. What questions should protein structure analysis answer?

 

The goal of protein structure analysis is not simply to obtain a structural image, but to explain how a protein carries out its function. A structural result has experimental value only if it can help answer questions about mutation, activity, binding, interaction, localization, or disease mechanism.

 

Research question	What structural analysis needs to examine	Follow-up validation experiments
Why does a mutation affect function?	Whether the mutated residue is located in the active site, binding pocket, hydrophobic core, flexible region, or subunit interface	Activity assays of mutant proteins, thermal stability experiments, binding assays, expression level analysis
Why can a small molecule inhibit the protein?	The binding site of the small molecule, key interacting residues, pocket shape, and conformational changes	Binding constant determination, enzyme inhibition assays, competitive binding experiments, validation with resistance mutations
Do two proteins form a complex?	Complex composition, subunit stoichiometry, interaction interface, and interface residues	Pull-down assays, co-immunoprecipitation, cross-linking mass spectrometry, interface mutagenesis
Does the protein undergo conformational changes?	Open state, closed state, flexible loops, disordered regions, and ligand-induced conformational changes	Hydrogen-deuterium exchange mass spectrometry, fluorescence-based distance change assays, structural comparison of different states
Is protein localization consistent with its structural state and function?	Whether localization signals, transmembrane regions, membrane-binding surfaces, or conformational and interaction features affecting localization are present	Immunofluorescence, cell fractionation, localization signal mutagenesis, cellular functional assays

 

The core logic of protein structure analysis is as follows: structural observation leads to mechanistic hypotheses, and functional experiments test whether those hypotheses are correct.

 

2. What structural levels does a protein have?

 

Protein structure is usually divided into four levels, and different levels correspond to different experimental questions.

 

Structural level	Question answered	Significance for scientific experiments
Primary structure	In what sequence are amino acids connected?	Identifying mutation sites and conserved residues, and inferring domain boundaries, signal peptides, transmembrane regions, and low-complexity regions through sequence analysis
Secondary structure	What regular conformations do local segments adopt?	Determining whether α-helices, β-sheets, turns, and flexible segments affect stability or function
Tertiary structure	How does a single polypeptide chain fold into a three-dimensional conformation?	Explaining the active site, ligand-binding pocket, surface charge, hydrophobic core, and domain arrangement
Quaternary structure	How do multiple subunits assemble into a complex?	Explaining protein interactions, subunit cooperativity, complex stability, and the effects of interface mutations

 

Proteins are not completely static molecules. Many proteins contain flexible loops, intrinsically disordered regions, multiple conformational states, ligand-induced changes, and post-translational modifications. Structural analysis should identify stable regions, while also assessing which regions may move, be absent, or cannot be described accurately by a single model.

 

3. The protein state must be defined before analysis

 

The same protein may adopt different structures in different states. Before starting an experiment, it is necessary to determine whether the object of study is the full-length protein, a domain fragment, a mutant, a complex, or a ligand-bound state.

 

Item to define	Specific question	Impact on experimental design
Protein boundaries	Will the study use the full-length protein, a domain fragment, or a truncation construct?	Determines construct length, tag position, expression system, and purification strategy
Binding state	Should substrate, inhibitor, cofactor, metal ions, or nucleic acids be included?	Determines whether the structure can reflect the true functional state
Complex state	Is the study focused on a single protein or a multisubunit complex?	Determines whether co-expression, in vitro reconstitution, or interface stabilization is required
Modification state	Are phosphorylation, glycosylation, disulfide bonds, or proteolytic processing required?	Determines the cellular expression system, purification conditions, and quality control methods
Mutation state	Is the comparison between wild type, disease mutants, or functional mutants?	Determines experimental grouping and the functional validation plan
Sample state	Is the protein stable, homogeneous, soluble, and non-aggregated?	Determines whether it is suitable to proceed to structural determination

 

Construct design directly affects the success or failure of a structural project. A well-designed construct should preserve complete domains as much as possible and avoid truncation in the middle of α-helices, β-sheets, or known functional regions. For long flexible tails, low-complexity regions, and degradation-prone segments, multiple truncation constructs can be designed to compare expression level, solubility, and stability.

 

4. How should commonly used protein structure analysis methods be selected?

 

Structural methods should be chosen according to the research question and the sample state. Experimental structures mainly come from X-ray crystallography, nuclear magnetic resonance, and cryo-electron microscopy, among other methods. In every case, the final structural model is derived from both experimental data and the modeling process.

 

Method	Problems it is suited to address	Main output	Main limitations
X-ray crystallography	High-resolution atomic structures, enzyme active sites, small-molecule binding, drug design	Atomic model, electron density map, resolution, structure refinement metrics	Requires crystals of sufficient quality; flexible proteins, membrane proteins, and unstable complexes are more difficult to handle
Nuclear magnetic resonance	Structures in solution, small to medium-sized proteins, flexible regions, conformational dynamics	Structural ensemble, interatomic distance restraints, local conformations, and dynamic information	Requires high sample concentration, stability, and isotopic labeling; large proteins often suffer from signal overlap
Cryo-electron microscopy	Large macromolecular complexes, membrane proteins, multiple conformational states, samples that are difficult to crystallize	Three-dimensional density map, atomic model, classification of different conformational states	Sample homogeneity, particle orientation, local resolution, and flexible regions can affect interpretation
Small-angle X-ray scattering	Overall shape in solution, complex size, trends in conformational changes	Low-resolution molecular envelope and structural restraints	Cannot independently provide a complete atomic structure
Hydrogen-deuterium exchange mass spectrometry	Protein surface exposure, protection effects caused by ligand binding, conformational changes	Peptide-level exchange changes	Spatial resolution is limited and requires interpretation together with structural models
Chemical cross-linking mass spectrometry	Adjacent regions within complexes, subunit proximity, interaction interfaces	Distance restraints between residues or peptides	Cross-linking coverage and reaction efficiency can limit conclusions
Fluorescence-based distance change assays	Distance changes between specific sites, real-time conformational transitions	Information on site-to-site distance changes and state transitions	Requires appropriate labeling sites and cannot directly resolve the full protein structure
Artificial intelligence-based structure prediction	Rapid generation of structural hypotheses, domain assessment, support for mutation design	Predicted models, per-residue confidence, indications of relative domain positions	Cannot replace experimental structures; low-confidence regions, complex interfaces, ligand states, and modification states require experimental validation

 

Artificial intelligence-based structure prediction is useful for providing structural hypotheses before experiments. The AlphaFold database contains more than 200 million predicted protein structures, and AlphaFold 3 can predict joint structures of complexes involving proteins, nucleic acids, small molecules, ions, and modified residues. Predicted results should be used as a basis for experimental design and mechanistic hypotheses, rather than being treated as final conclusions without validation.

 

5. Experimental workflow from sample to result

 

Protein structure analysis should proceed in the order of question, sample, method, result, and validation.

 

Stage	Tasks to complete	Acceptance criteria
1. Define the question	Determine whether the goal is to explain mutation, activity, binding, interaction, conformational change, or localization	The question can be translated into measurable indicators
2. Sequence analysis	Analyze domains, transmembrane regions, signal peptides, conserved sites, low-complexity regions, and disordered regions	Reasonable construct boundaries are obtained
3. Database search	Search for existing experimental structures, homologous structures, predicted structures, and reported functional sites	Clarify which regions are already supported by evidence and which still require experimental investigation
4. Construct design	Design full-length, domain, truncation, mutant, or complex constructs	At least soluble, stable, and functionally relevant samples are obtained
5. Sample quality control	Check purity, aggregation state, degradation, complex composition, and thermal stability	The sample is homogeneous, stable, and reproducible across batches
6. Data collection	Choose structural determination, structural restraint, or prediction-assisted strategies based on sample state	The data can answer the original question
7. Structural interpretation	Analyze active sites, binding pockets, interfaces, flexible regions, and the positions of mutated residues	Obtain mechanistic hypotheses that can be tested experimentally
8. Functional validation	Use mutation, activity, binding, localization, or cellular experiments to test structural hypotheses	Structural changes correspond to functional changes

 

Sample quality control is the foundation of structural analysis. Protein degradation, aggregation, missing cofactors, complex dissociation, unsuitable buffer conditions, and conformational heterogeneity can all lead to failure in structure determination or make results difficult to interpret. When sample quality is inadequate, priority should be given to optimizing the construct, expression system, purification workflow, and buffer conditions.

 

6. How can protein expression and localization atlas information complement structural analysis?

 

Protein expression and localization atlas information answers questions such as where a protein is expressed, in which cell types it appears, which cellular structure it localizes to, and which molecules it may be associated with. It does not directly resolve atomic-level three-dimensional structure. Its value lies in providing tissue, cellular, and disease context for structural results.

 

The Human Protein Atlas contains resources on tissues, brain, single-cell types, pathology, blood, subcellular localization, cell lines, structure, and interactions, and can be used to query protein expression, localization, and disease-related clues.

 

Atlas content	Question answered	How it helps structural research
Tissue expression	In which tissues is the protein mainly expressed?	Helps determine whether the target protein is relevant to disease-associated tissues
Single-cell expression	Which cell types express the target protein?	Helps select appropriate cell models and validation targets
Subcellular localization	Is the protein located in the nucleus, mitochondria, membrane systems, or cytosol?	Helps determine whether structural function is consistent with cellular location
Disease-related expression	Is protein expression associated with tumors, immune states, or other disease conditions?	Helps identify potential biomarkers or drug targets
Interaction information	With which molecules may the protein act together?	Provides candidate interaction partners for complex structure analysis
Structure and variation information	Where do mutations or antigenic regions fall within the structure?	Helps explain disease mutations, antibody recognition, and functional sites

 

Protein atlas information does not replace structural determination. It is most useful when used together with structural results: structural analysis explains molecular mechanisms, while atlas information indicates whether those mechanisms occur in relevant tissues, cell types, and disease contexts.

 

7. How to judge whether a structural result is reliable

 

A structural model should not be judged solely by whether the image looks clear. Reliable conclusions require simultaneous evaluation of the quality of the experimental data, the geometric quality of the model, and the degree of agreement between the model and the experimental data. The validation reports provided by the Worldwide Protein Data Bank (wwPDB) are specifically used to assess structural models, experimental data, and the correspondence between them.

 

Result type	What needs to be checked	Common risks
X-ray crystal structure	Resolution, electron density map, R-work, R-free, B-factors, and geometric reasonableness	Over-interpreting side chains despite insufficient resolution; assigning ligands without clear electron density; overlooking flexible regions
NMR structure	Number of experimental restraints, restraint distribution, convergence of the structural ensemble, and differences in flexible regions	Looking only at a single model rather than the full ensemble; interpreting weakly restrained regions as overly certain
Cryo-EM structure	Overall resolution, local resolution, fit between the density map and the model, particle classification, and orientation distribution	Interpreting atomic details in regions with poor local resolution; forcing models into flexible regions
AI-predicted structure	Per-residue confidence, relative domain position error, and interface confidence	Treating low-confidence regions as definite structures; treating predicted complex interfaces as experimental facts
Integrative structural model	Source of experimental restraints, restraint coverage, and whether different types of data support one another	Over-interpreting low-resolution data as atomic-level mechanisms

 

Not every region in a structural database model is equally reliable. Core protein domains are usually supported by more reliable evidence than flexible tails, linker regions, disordered regions, surface loops, or complex interfaces. When interpreting function, priority should be given to regions that are well supported by data.

 

8. How structural results lead back to functional validation

 

Structural analysis generates mechanistic hypotheses, while functional experiments determine whether those hypotheses are correct. A complete study should form a closed loop of structural observation, testable hypothesis, functional validation, and mechanistic conclusion.

 

Structural observation	Hypothesis that can be proposed	Recommended validation experiments	Conclusion that can be supported
The mutation lies in the hydrophobic core	The mutation reduces protein stability	Thermal stability experiments, protein degradation assays, expression level analysis	The loss of function may result from impaired folding or reduced stability
The mutation lies in the active site	The mutation affects catalysis	Enzyme activity assays, substrate-binding experiments, rescue of key residues	The loss of function results from disruption of the catalytic center
The mutation lies at a protein interaction interface	The mutation disrupts complex formation	Pull-down assays, co-immunoprecipitation, cross-linking mass spectrometry, interface mutagenesis	The loss of function results from impaired interaction
The small molecule lies in the binding pocket	The small molecule inhibits the protein through a specific site	Binding constant determination, competition experiments, validation with resistance mutations	The inhibitory effect is related to the structural pocket
A flexible loop is close to the active site	Conformational change regulates activity	Structural comparison of different ligand-bound states, hydrogen-deuterium exchange mass spectrometry, fluorescence-based distance change assays	Activity may be controlled by a conformational switch
A localization signal is exposed or absent	Mislocalization of the protein affects function	Immunofluorescence, cell fractionation, localization signal mutagenesis	Functional abnormality is related to cellular location

 

9. Classification, features, and applications of representative chemicals related to protein structure analysis (Tables 1-4)

 

Table 1 | Buffer systems, crystallization precipitants, and crystallization additives

 

Classification	CAS No.	Aladdin Cat. No.	Name	Specification or purity	Product features and applications
Crystallization precipitant / salting-out agent	7783-20-2	A112104	Ammonium sulfate	For plant cell culture, ≥99%	A classic protein crystallization precipitant and salting-out agent, suitable for crystal screening, stepwise protein precipitation, and ionic strength optimization
Neutral buffer system component	1185-53-1	T105291	Tris(hydroxymethyl)aminomethane hydrochloride	For cell culture, molecular biology grade, ≥99%(AT)	Commonly used for protein extraction, purification, refolding, and preparation of samples for structural determination, suitable for maintaining protein conformation under neutral to mildly alkaline conditions
Mildly acidic buffer system component	4432-31-9	M108951	MES	Molecular biology grade, ≥99.5%(T)	Suitable for buffer systems from mildly acidic to near-neutral pH, and can be used for acid-sensitive proteins, enzyme activity condition screening, and crystallization system preparation
Crystallization precipitant	25322-68-3	P432429	Poly(ethylene glycol)（PEG）	average Mn3350	A frequently used protein crystallization precipitant that can regulate the desolvation process, suitable for crystal screening, crystal optimization, and exploration of crystallization conditions for complexes
Crystallization additive / cryoprotectant	107-41-5	M420527	2-Methyl-2,4-pentanediol	10mM in DMSO	A commonly used crystallization additive and cryoprotective component, suitable for improving crystal formation, reducing freezing damage, and assisting condition screening for difficult-to-crystallize samples
Neutral buffer system component	7365-45-9	H433402	HEPES buffer solution	1 M in H2O	A commonly used buffer system close to physiological conditions, suitable for protein complex preparation, maintenance of activity, and preparation of sample buffers for structural analysis

 

Table 2 | Reagents related to protein purification, reducing protection, and sample stability

 

Classification	CAS No.	Aladdin Cat. No.	Name	Specification or purity	Product features and applications
Affinity purification elution component	6363-53-7	M433180	Maltose monohydrate	Pharmaceutical grade, PharmPure™	Commonly used for affinity elution of maltose-binding protein-tagged proteins, and can also be used as a sugar additive to evaluate protein stability and conformational preservation
Metal chelate affinity purification elution component	288-32-4	I432539	Imidazole	Anhydrous, ACS, ≥99%	Commonly used for elution and gradient optimization in immobilized metal affinity purification of His-tagged proteins, helping obtain high-purity structural samples
Thiol reducing agent	3483-12-3	D104860	DL-Dithiothreitol(DTT)	Molecular biology grade, ≥99%	Used to maintain cysteine residues in a reduced state and reduce nonspecific disulfide bond formation, commonly applied in soluble protein purification and protection of structural samples
Sample stabilizer / cryoprotectant	56-81-5	G116208	Glycerol	Molecular biology grade, ≥99%	Can improve the stability of protein solutions, reduce freeze-thaw damage and aggregation risk, and is also commonly used for sample storage and cryoprotection
Non-thiol reducing agent	51805-45-9	T755610	Tris(2-carboxyethyl)phosphine hydrochloride(TCEP HCl)	UltraBio™, suitable for electrophoresis, SDS-PAGE tested	Suitable for reduction of samples containing disulfide bonds, sample handling before and after cross-linking, and electrophoresis-compatible systems, helping maintain a reducing environment
Affinity purification elution component / redox regulator	70-18-8	G105427	Glutathione (Reduced) (GSH)	Moligand™, for cell culture, ≥98%	Commonly used for elution of glutathione S-transferase-tagged proteins, and can also regulate the redox environment to support the stability of proteins containing thiol groups

 

Table 3 | Reagents related to membrane protein solubilization, membrane environment stabilization, and complex preservation

 

Classification	CAS No.	Aladdin Cat. No.	Name	Specification or purity	Product features and applications
Mild membrane protein detergent	69227-93-6	N475300	n-Dodecyl β-D-maltoside （DDM）	UltraBio™, ultrapure, ≥98%	Commonly used for membrane protein extraction, purification, and complex preservation, and can maintain membrane protein solubility and homogeneity under relatively mild conditions
Cholesterol-like membrane environment stabilizing additive	1510-21-0	C132483	Cholesteryl hemisuccinate(CHEMS)	Moligand™,≥97%	When used together with detergents or lipid systems, it can introduce a cholesterol-like environment and help maintain the folding, activity, and complex integrity of certain membrane proteins
Steroidal membrane protein stabilizer	1402423-29-3	G650685	Glyco-diosgenin	≥98%	Suitable for membrane protein extraction, purification, and preparation of structural samples, helping maintain the stability and dispersion of certain membrane protein complexes
Neopentyl glycol membrane protein detergent	1257852-96-2	L650802	Lauryl maltose neopentyl glycol	≥98%	Commonly used for membrane protein extraction, purification, and long-term stable storage, and can support homogeneity assessment and structural analysis of membrane protein complexes

 

Table 4 | Reagents related to NMR isotope labeling, cross-linking, and interaction analysis

 

Classification	CAS No.	Aladdin Cat. No.	Name	Specification or purity	Product features and applications
Fixative / short-range cross-linking reagent	50-00-0	F491227	Formaldehyde solution (for vaccine)	Pharmaceutical grade, PharmPure™, 10% in water	Suitable for fixing cells or preserving sample states, helping capture transient interactions, and commonly used in sample preparation before imaging or in situ cross-linking
NMR solvent / hydrogen-deuterium exchange medium	7789-20-0	D113904	Deuterium oxide	≥99.9 atom% D	A commonly used solvent for NMR measurements, also suitable for hydrogen-deuterium exchange experiments and analysis of exchangeable hydrogen signals
NMR isotopic nitrogen source	39466-62-1	A117712	Ammonium chloride-15N	≥99 atom%,≥98%	A commonly used nitrogen source in prokaryotic expression systems, suitable for preparing nitrogen-labeled proteins to support NMR structural and dynamics studies
NMR isotopic carbon source	110187-42-3	D346444	D-Glucose-¹³C₆	≥99 atom% 13C,≥98%	A commonly used carbon source in prokaryotic expression systems, suitable for preparing carbon-labeled proteins to support multidimensional NMR spectral analysis
Amine-reactive cross-linker	68528-80-3	D155694	Di(N-succinimidyl) Suberate	≥98%	Can provide lysine-to-lysine distance restraints, suitable for analysis of protein interaction interfaces, conformational studies of complexes, and preparation of samples for cross-linking mass spectrometry
Water-soluble amine-reactive cross-linker	127634-19-9	S304724	Suberic acid bis(3-sulfo-N-hydroxysuccinimide ester) sodium salt(Sulfo-DSS 2Na)	≥95%	Suitable for protein cross-linking and cross-linking mass spectrometry analysis in aqueous systems, facilitating capture of soluble protein complexes and interaction information

 

Note: The products listed above are representative Aladdin products. For more product specifications, search the Aladdin website using the product name, CAS number, or catalog number.

 

References

 

[1] Berman H. M., Westbrook J., Feng Z., et al. The Protein Data Bank. Nucleic Acids Research. 2000;28(1):235-242. DOI: 10.1093/nar/28.1.235.

 

[2] RCSB PDB-101. Methods for Determining Structure.

 

[3] Gore S., Sanz García E., Hendrickx P. M. S., et al. Validation of Structures in the Protein Data Bank. Structure. 2017;25(12):1916-1927. DOI: 10.1016/j.str.2017.10.009.

 

[4] wwPDB. Validation Reports.

 

[5] Jumper J., Evans R., Pritzel A., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583-589. DOI: 10.1038/s41586-021-03819-2.

 

[6] Varadi M., Bertoni D., Magana P., et al. AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Research. 2024;52(D1):D368-D375. DOI: 10.1093/nar/gkad1011.

 

[7] Abramson J., Adler J., Dunger J., et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493-500. DOI: 10.1038/s41586-024-07487-w.

 

[8] Uhlén M., Fagerberg L., Hallström B. M., et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. DOI: 10.1126/science.1260419.

 

[9] Digre A., Lindskog C. The human protein atlas: Integrated omics for single cell mapping of the human proteome. Protein Science. 2023;32(2):e4562. DOI: 10.1002/pro.4562.

 

For more related articles, see below:

 

How to Choose the Best Protein Purification Technique

 

Structural and Catalytic Roles of Metal Ions in Protein Enzyme Activity

 

Protein Molecular Weight Standards

 

How to Elute Biotinylated Proteins and Nucleic Acids from Streptavidin Beads？